tradingkey.logo

Work Medical Technology Group Ltd

WOK
0.033USD
-0.016-32.92%
收盘 12/24, 13:00美东报价延迟15分钟
4.79K总市值
--市盈率 TTM

Work Medical Technology Group Ltd

0.033
-0.016-32.92%

关于 Work Medical Technology Group Ltd 公司

Work Medical Technology Group Ltd is a holding company mainly engaged in the manufacturing of medical devices. The Company's main products include medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, guedel airways, and other Class I disposable medical devices, disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kit, oxygen face masks, anesthesia masks, laryngoscope blades, yankauer suction sets, nasal oxygen cannulas, and other Class II disposable medical devices, KN95 masks, filtering half mask, and other medical devices, as well as medical innovative devices and equipment, such as visualized prostatic dilatation catheter. The Company principally conducts its businesses in domestic and overseas markets, such as Asia, Africa, Europe, North America, South America, and Oceania.

Work Medical Technology Group Ltd简介

公司代码WOK
公司名称Work Medical Technology Group Ltd
上市日期Aug 23, 2024
CEOWu (Shuang)
员工数量229
证券类型Ordinary Share
年结日Aug 23
公司地址Building 23, No. 2 Tonghuinan Rd., Xiaoshan District
城市HANGZHOU
上市交易所NASDAQ OMX - NASDAQ BASIC
国家China
邮编311200
电话8657182613568
网址https://www.workmedtech.com/
公司代码WOK
上市日期Aug 23, 2024
CEOWu (Shuang)

Work Medical Technology Group Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Xiaoyang Li
Mr. Xiaoyang Li
Independent Director
Independent Director
--
--
Mr. Zhongxuan Li
Mr. Zhongxuan Li
Independent Director
Independent Director
--
--
Mr. Shuang Wu
Mr. Shuang Wu
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ningfang Liang
Mr. Ningfang Liang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Baiming Yu
Mr. Baiming Yu
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Robert Johnson
Mr. Robert Johnson
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2023
FY2022
FY2021
FY2020
业务USD
名称
营收
占比
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%
地区USD
名称
营收
占比
China
12.60M
92.87%
Overseas market
967.69K
7.13%
业务
地区
业务USD
名称
营收
占比
Others
13.72M
0.00%
Medical devices other than masks
8.00M
58.95%
Marks
5.09M
37.53%
Commodity trading
325.43K
2.40%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
LWY GROUP LTD
6.51%
Sabby Management, LLC
2.84%
Virtu Americas LLC
0.32%
Desjardins Securities Inc.
0.21%
Two Sigma Investments, LP
0.05%
其他
90.07%
持股股东
持股股东
占比
LWY GROUP LTD
6.51%
Sabby Management, LLC
2.84%
Virtu Americas LLC
0.32%
Desjardins Securities Inc.
0.21%
Two Sigma Investments, LP
0.05%
其他
90.07%
股东类型
持股股东
占比
Corporation
6.51%
Investment Advisor/Hedge Fund
2.84%
Research Firm
0.53%
Hedge Fund
0.07%
Venture Capital
0.04%
其他
90.01%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
9
79.91K
8.32%
+78.09K
2025Q2
8
6.35M
12.98%
-18.36K
2025Q1
8
6.35M
37.37%
-18.36K
2024Q4
14
12.62M
86.49%
+6.36M
2024Q3
10
12.51M
85.72%
+12.51M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
LWY GROUP LTD
6.25M
6.51%
--
--
Feb 14, 2025
Virtu Americas LLC
--
0%
-40.01K
-100.00%
Mar 31, 2025
Two Sigma Investments, LP
--
0%
-11.39K
-100.00%
Jun 30, 2025
XTX Markets LLC
--
0%
-19.16K
-100.00%
Jun 30, 2025
Citadel Advisors LLC
29.65K
0.03%
-19.92K
-40.18%
Jun 30, 2025
UBS Financial Services, Inc.
52.41K
0.05%
+30.05K
+134.37%
Jun 30, 2025
HRT Financial LP
--
0%
-23.60K
-100.00%
Mar 31, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Oct 17, 2025
Merger
100→1
公告日期
类型
比率
Oct 17, 2025
Merger
100→1

常见问题

Work Medical Technology Group Ltd的前五大股东是谁?

Work Medical Technology Group Ltd 的前五大股东如下:
LWY GROUP LTD持有股份:6.25M,占总股份比例:6.51%。
Virtu Americas LLC持有股份:0.00,占总股份比例:0.00%。
Two Sigma Investments, LP持有股份:0.00,占总股份比例:0.00%。
XTX Markets LLC持有股份:0.00,占总股份比例:0.00%。
Citadel Advisors LLC持有股份:29.65K,占总股份比例:0.03%。

Work Medical Technology Group Ltd的前三大股东类型是什么?

Work Medical Technology Group Ltd 的前三大股东类型分别是:
LWY GROUP LTD
Sabby Management, LLC
Virtu Americas LLC

有多少机构持有Work Medical Technology Group Ltd(WOK)的股份?

截至2025Q3,共有9家机构持有Work Medical Technology Group Ltd的股份,合计持有的股份价值约为79.91K,占公司总股份的8.32%。与2025Q2相比,机构持股有所增加,增幅为-4.66%。

哪个业务部门对Work Medical Technology Group Ltd的收入贡献最大?

在FY2023,Others业务部门对Work Medical Technology Group Ltd的收入贡献最大,创收13.72M,占总收入的--%。
KeyAI